Drug & Device Safety Atlas
New York
297 FDA recall enforcement records from firms headquartered in New York: 27 Class I, 258 Class II, 12 Class III. Grouped by recalling firm's headquarters state, not distribution. Source: FDA/openFDA. Not medical advice. CC0.
New York (NY) has 297 FDA recalls from firms headquartered there
Aggregation
297 FDA recall enforcement records are associated with firms headquartered in New York (NY) — 105 drug, 192 device; 27 Class I (most serious), 258 Class II, 12 Class III; 235 ongoing. An AGGREGATED count of openFDA enforcement records keyed by the recalling firm's headquarters state (occurred=true; adjudged=FALSE — the Atlas counted; FDA published the records). Source: FDA/openFDA since 2023.
How to read this claim
occurred=TRUE: a faithful COUNT/SUM/total over the named record set that introduces NO modeling choice — it IS the case in the record. adjudged=FALSE: Atlas Commons computed the aggregate; openFDA drug & device recall enforcement records — U.S. FDA published the underlying records, NOT this figure. Re-count it from the named source to verify. Distinct from a median/ratio/index (which picks a population, weighting, denominator, or threshold — a constructed statistic → 'derived', occurred=FALSE) and from an authority-published total (→ 'recorded', adjudged=TRUE).
State grouping is by recalling firm's headquarters address, not distribution or manufacture state
Interpretation
These recalls are grouped by the recalling firm's headquarters state (New York), not by where the recalled product was manufactured, distributed, or where harm occurred. A large recall count reflects business volume — the Class I count and ongoing status are the decision-relevant signals. Not medical advice.
How to read this claim
occurred=FALSE (a framing, not an event) and adjudged=FALSE (an in-house reading, not an authority's verdict) — the LOWEST-warrant claim here. A flat representation would render this identically to the official facts; the four-status does not.